Bharat Bio successfully completes Phase III trials of new oral...

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

Postado

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.

Read Full Article

Faça Login para curtir, compartilhar e comentar!

Sports

'Ended extremely poorly': Parth Jindal apologises to fans as DC crash out

Delhi Capitals co-owner Parth Jindal apologised to fans after their IPL 2025 playoff hopes were...

Por 0 0

National

Cessation of firing and military action negotiated directly between India, Pakistan: Jaishankar

AMSTERDAM: India’s External Affairs Minister S Jaishankar has said that the cessation of...

Por 0 0

Entertainment

Suhana Khan turns 25, BFFs send love & hugs

Suhana Khan celebrated her 25th birthday on May 22, 2025, with heartfelt wishes from close...

Por 0 0

International

House Republicans launch an all-nighter to try to pass Trump's big bill

House Republicans, led by Speaker Mike Johnson, are pushing forward with President Trump's...

Por 0 13

Sports

India U-19 tour of England: Mhatre to lead, Sooryavanshi named in squad

Ayush Mhatre, a 17-year-old Mumbai opener, has been appointed as the captain of the India U-19...

Por 0 13